Intellectual Property

Vaccination

blog
Vaccine Hesitancy, Working from Home, Arctic Diplomacy: RAND Weekly Recap
This weekly recap focuses on vaccine hesitancy as a symptom of ‘Truth Decay,’ how to make remote work beneficial for all, U.S. Arctic diplomacy, and more.
Read More »
May 21, 2021

Vaccination

commentary
Vaccine Patents Debate Risks Becoming a Sideshow in the Global Battle Against COVID-19
As COVID-19 cases continue to surge around the world, the debate is raging over whether patents on existing vaccines should be waived. But the global community could view patent waivers as just one of many available tools for speeding up vaccine delivery worldwide.
Read More »
May 17, 2021
The Hill
Krishna B. Kumar @kbkumar_
Science and Technology Legislation

commentary
Scientific Research Integrity Demands Transparency—the Law Should Require It Too
China pays U.S. scientists for their innovations in exchange for money and access to research laboratories and speaking and publication opportunities. They require the researchers to keep these agreements secret from their employers or the U.S. government. Perhaps it is time to codify scientific transparency into law.
Read More »
Apr 12, 2021
Cortney Weinbaum @cortney_dc
Vaccination

commentary
Needed: A Blueprint for a Post-Vaccine World
When a COVID-19 vaccine is developed, many in rich countries may be able to afford it while the poor and uninsured may not. The time to plan for equitable access, financing, intellectual property rights, and global production is now.
Read More »
May 11, 2020
The Hill
Krishna B. Kumar @kbkumar_, Mahshid Abir, et al.
Data Privacy

commentary
ACTA Revisited? TTIP and Data Privacy
The EU has embarked on negotiations with the U.S. on the TTIP, which shares some of ACTA's goals. This time, though, the European Commission is seeking to make the talks more transparent by publishing a series of position papers on key issues very early on in the process. This is a step in the right direction toward an agreement that will have economic benefits for a net-exporting region of intellectual property such as the EU.
Read More »
Nov 26, 2014
Atlantic Community
Marlon Graf
Science, Technology, and Innovation Policy

commentary
A New Model for Open Innovation: The Structural Genomics Consortium
Open innovation is often suggested as a solution to enhance productivity in under-performing areas of research. Now, the strengths and weaknesses of a new open innovation model in drug discovery have been evaluated.
Read More »
Mar 25, 2014
EuroScientist
Sophie Castle-Clarke
Intellectual Property

commentary
The Costs of Counterfeiting
A new RAND report points to a potential solution to understanding the real economic losses associated with intellectual property infringement.
Read More »
Nov 28, 2012
The RAND Blog
Stijn Hoorens @StijnHoorens

Quoted

The Biden administration's lack of a competitive economic strategy, not just in Oceania but throughout the Indo-Pacific, is providing China with unique opportunities to leverage its Belt and Road Initiative to deepen trade, investment, and infrastructure development. Chinese economic overtures tend to be successful, given that Pacific Island countries are overwhelmingly small and impoverished.

Derek Grossman

Senior Defense Analyst

Source: Foreign Policy

While neurodivergent diagnoses are not automatically disqualifying from Army service, any new recruit who reveals a diagnosis jumps through hoops to serve. Some described having to prove that their diagnoses do not impede their ability to serve, which puts the burden on an eighteen-year-old to prove a negative for which the Army has no assessment criteria.

Cortney Weinbaum

Senior Management Scientist

Source: Modern War Institute (West Point)

Now Is the Time for Space Traffic Management

Which Working Conditions Could Restore Teacher Well-Being?

Amid an Epidemic of Loneliness, Nonprofits Are Helping Keep Veterans Connected

America Is Winning Against China in Oceania

What Does Environmental Justice Look Like?

The Policy Currents Podcast

Helping Coastal Communities Plan for Climate Change

Managing Escalation in Crisis and War

Measuring Wellbeing to Help Communities Thrive

Assessing and Articulating the Wider Benefits of Research

Intellectual Property

Vaccine Hesitancy, Working from Home, Arctic Diplomacy: RAND Weekly Recap

Vaccine Patents Debate Risks Becoming a Sideshow in the Global Battle Against COVID-19

Scientific Research Integrity Demands Transparency—the Law Should Require It Too

Needed: A Blueprint for a Post-Vaccine World

ACTA Revisited? TTIP and Data Privacy

A New Model for Open Innovation: The Structural Genomics Consortium

The Costs of Counterfeiting

Connect

Contact Us

I am interested in

Follow

Stay Informed

Resources

Site Information